- Sarepta Therapeutics Provides Clarifying Statement on ELEVIDYS Sarepta Therapeutics
- The crisis over Sarepta’s Duchenne therapy is a mess. But the lesson is clear statnews.com
- FDA probes death of patient on Sarepta’s Elevidys, partner Roche says death unrelated to therapy Reuters
- ‘We will crack gene therapy’: Elevidys fallout doesn’t dent Roche’s hopes for modality Fierce Biotech
- FDA weighs new study requirements for Sarepta to confirm safety of gene therapy Elevidys: report Fierce Pharma
Source link
